Skip to main content
HR 4821 107th Congress House

Fair Advertising and Increased Research (FAIR) Act

Official title: To amend the Internal Revenue Code of 1986 to limit the deduction for advertising of FDA approved prescription drugs by the manufacturer of such drugs to the l… Show full official titleShow less

Official title: To amend the Internal Revenue Code of 1986 to limit the deduction for advertising of FDA approved prescription drugs by the manufacturer of such drugs to the level of such manufacturer's research and development expenditures, and for other purposes.

Introduced: May 22, 2002 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Taxation AdvertisingAppropriationsBusiness income taxCommerce
More subjectsShow fewer subjects
Drug industryEconomics and Public FinanceGovernment Operations and PoliticsGovernment trust fundsHealthIncome taxMarketingMedicarePharmaceutical researchResearch and developmentSales promotionScience, Technology, CommunicationsSocial WelfareTax deductions
Sign in to write a letter Sign in to watch
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2002
Referred to the House Committee on Ways and Means.
May 22, 2002
Introduced in House
May 20, 2002
Sponsor introductory remarks on measure. (CR H2651)
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 22, 2002

Referred to the House Committee on Ways and Means.

 Plain-English summary Congressional Research Service
Fair Advertising and Increased Research Act - Amends the Internal Revenue Code to prohibit any drug manufacturer from taking a tax deduction for expenditures relating to the advertising, promoting, or marketing of any FDA prescription drug to the extent the aggregate amount of such expenditures exceeds the manufacturer's aggregate research and development expenditures.

Directs the Secretary of the Treasury to estimate amount of additional tax revenues raised by enforcement of the Act, to be allocated to the Federal Hospital Insurance Trust Fund.

 Related & companion bills 1
  • S 2486 Companion bill Fair Advertising and Increased Research (FAIR) Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 2 Independent 1
D
Davis, Danny K.
Illinois · Jun 25, 2002
 D
DeLauro, Rosa L.
Connecticut · May 22, 2002
 I
Sanders, Bernard
Vermont · May 22, 2002
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4821: Fair Advertising and Increased Research (FAIR) Act. 107th Congress. Open America. https://openamerica.io/bill/107-HR-4821/
MLA
"H.R. 4821: Fair Advertising and Increased Research (FAIR) Act." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-4821/.
Bluebook (legal)
H.R. 4821, 107th Cong. (2026), https://openamerica.io/bill/107-HR-4821/.
Markdown link
[H.R. 4821: Fair Advertising and Increased Research (FAIR) Act](https://openamerica.io/bill/107-HR-4821/)
Report a problem